AWM
AVNS

Aberdeen Wealth Management’s Avanos Medical AVNS Stock Holding History

Aberdeen Wealth Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.42K Buy
+218
New +$5.1K ﹤0.01% 362

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Aberdeen Wealth Management's AVNS Position: Q2 2026 in Review

Aberdeen Wealth Management opened a new position in Avanos Medical (AVNS) in Q2 2026: 218 shares worth $5.42K. The stake represents ﹤0.01% of the portfolio and ranks #362 among its holdings.

287 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Aberdeen Wealth Management held 218 shares of Avanos Medical worth $5.42K as of Q2 2026.
  • Avanos Medical was a new Aberdeen Wealth Management position in Q2 2026.
  • Avanos Medical made up ﹤0.01% of Aberdeen Wealth Management's portfolio in Q2 2026, its #362 holding.
  • 287 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Aberdeen Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.